Skip to main content
Top
Published in:

Open Access 09-05-2024 | Pseudomonas Aeruginosa | Original Research

Distribution of Nosocomial Pathogens and Antimicrobial Resistance among Patients with Burn Injuries in China: A Comprehensive Research Synopsis and Meta-Analysis

Authors: Yuhui Yang, Qingling Zeng, Guangyun Hu, Zhenkun Wang, Zongyue Chen, Lang Zhou, Aibo He, Wei Qian, Yu Luo, Gaoming Li

Published in: Infectious Diseases and Therapy | Issue 6/2024

Login to get access

Abstract

Introduction

Over the past decade, numerous studies have described the types of pathogens and their antibiotic resistance patterns in patients with burn injuries in China; however, the findings have generally been inconsistent. We conducted a literature search and meta-analysis to summarize the infection spectra and antimicrobial resistance patterns in patients with burn injuries.

Methods

We searched the PubMed, Embase, Web of Science, China National Knowledge Infrastructure, China Biomedical Literature, Wanfang, and Weipu databases for relevant articles published between January 2010 and December 2023. The DerSimonian–Laird random-effects model was used to estimate the proportions and 95% confidence intervals (CIs) of pathogens among Chinese patients with burn injuries. Meta-regression analyses were performed to explore differences in the proportions of pathogens among different subgroups and their resistance patterns. This study was registered with PROSPERO (CRD42024514386).

Results

The database searches yielded 2017 records; after removing duplicates and conducting initial screening, 219 articles underwent full-text screening. Ultimately, 60 studies comprising a total of 62,819 isolated strains reported the proportions of pathogens in patients with burn injuries and were included in this meta-analysis. Meta-analyses were conducted on 18 types of pathogens. The most common pathogens causing infections in Chinese patients with burn injuries were Staphylococcus aureus, Pseudomonas aeruginosa, Acinetobacter baumannii, Klebsiella pneumoniae, and Staphylococcus epidermidis. Similar results were observed in the subgroup analysis focusing on wound infections. Since 2015, there has been a significant decrease in the proportion of Pseudomonas aeruginosa (R2 = 4.89%) and a significant increase in the proportion of Klebsiella pneumoniae (R2 = 9.60%). In terms of antibiotic resistance, there has been a significant decrease in the resistance of Staphylococcus aureus to multiple antibiotics and an increasing trend in the resistance of Klebsiella pneumoniae.

Conclusions

We systematically summarized the epidemiological characteristics and antibiotic resistance patterns of pathogens among individuals suffering from burns in China, thus providing guidance for controlling wound infections and promoting optimal empirical antimicrobial therapy. The observed high levels of antibiotic resistance underscore the need for ongoing monitoring of antibiotic usage trends.
Appendix
Available only for authorised users
Literature
1.
go back to reference Price K, Lee KC, Woolley KE, et al. Burn injury prevention in low- and middle- income countries: scoping systematic review. Burns Trauma. 2021;9:tkab037.PubMedPubMedCentralCrossRef Price K, Lee KC, Woolley KE, et al. Burn injury prevention in low- and middle- income countries: scoping systematic review. Burns Trauma. 2021;9:tkab037.PubMedPubMedCentralCrossRef
2.
go back to reference James SL, Lucchesi LR, Bisignano C, et al. Epidemiology of injuries from fire, heat and hot substances: global, regional and national morbidity and mortality estimates from the Global Burden of Disease 2017 study. Inj Prev. 2020;26(Supp 1):i36–45.PubMedCrossRef James SL, Lucchesi LR, Bisignano C, et al. Epidemiology of injuries from fire, heat and hot substances: global, regional and national morbidity and mortality estimates from the Global Burden of Disease 2017 study. Inj Prev. 2020;26(Supp 1):i36–45.PubMedCrossRef
3.
4.
go back to reference Dabrowska AK, Spano F, Derler S, Adlhart C, Spencer ND, Rossi RM. The relationship between skin function, barrier properties, and body-dependent factors. Skin Res Technol. 2018;24(2):165–74.PubMedCrossRef Dabrowska AK, Spano F, Derler S, Adlhart C, Spencer ND, Rossi RM. The relationship between skin function, barrier properties, and body-dependent factors. Skin Res Technol. 2018;24(2):165–74.PubMedCrossRef
5.
go back to reference Pruitt BA Jr, McManus AT, Kim SH, Goodwin CW. Burn wound infections: current status. World J Surg. 1998;22(2):135–45.PubMedCrossRef Pruitt BA Jr, McManus AT, Kim SH, Goodwin CW. Burn wound infections: current status. World J Surg. 1998;22(2):135–45.PubMedCrossRef
7.
go back to reference Saaiq M, Ahmad S, Zaib MS. Burn wound infections and antibiotic susceptibility patterns at Pakistan Institute of Medical Sciences, Islamabad, Pakistan. World J Plast Surg. 2015;4(1):9–15.PubMedPubMedCentral Saaiq M, Ahmad S, Zaib MS. Burn wound infections and antibiotic susceptibility patterns at Pakistan Institute of Medical Sciences, Islamabad, Pakistan. World J Plast Surg. 2015;4(1):9–15.PubMedPubMedCentral
8.
go back to reference Lachiewicz AM, Hauck CG, Weber DJ, Cairns BA, van Duin D. Bacterial infections after burn injuries: impact of multidrug resistance. Clin Infect Dis. 2017;65(12):2130–6.PubMedPubMedCentralCrossRef Lachiewicz AM, Hauck CG, Weber DJ, Cairns BA, van Duin D. Bacterial infections after burn injuries: impact of multidrug resistance. Clin Infect Dis. 2017;65(12):2130–6.PubMedPubMedCentralCrossRef
9.
go back to reference van Duin D, Strassle PD, DiBiase LM, et al. Timeline of health care-associated infections and pathogens after burn injuries. Am J Infect Control. 2016;44(12):1511–6.PubMedPubMedCentralCrossRef van Duin D, Strassle PD, DiBiase LM, et al. Timeline of health care-associated infections and pathogens after burn injuries. Am J Infect Control. 2016;44(12):1511–6.PubMedPubMedCentralCrossRef
10.
go back to reference Wanis M, Walker SAN, Daneman N, et al. Impact of hospital length of stay on the distribution of Gram negative bacteria and likelihood of isolating a resistant organism in a Canadian burn center. Burns. 2016;42(1):104–11.PubMedCrossRef Wanis M, Walker SAN, Daneman N, et al. Impact of hospital length of stay on the distribution of Gram negative bacteria and likelihood of isolating a resistant organism in a Canadian burn center. Burns. 2016;42(1):104–11.PubMedCrossRef
12.
go back to reference Norbury W, Herndon DN, Tanksley J, Jeschke MG, Finnerty CC. Infection in burns. Surg Infect (Larchmt). 2016;17(2):250–5.PubMedCrossRef Norbury W, Herndon DN, Tanksley J, Jeschke MG, Finnerty CC. Infection in burns. Surg Infect (Larchmt). 2016;17(2):250–5.PubMedCrossRef
13.
go back to reference Zhou S, Xiao S, Wang X, Wang X, Han L. Risk factors and pathogens of wound infection in burn inpatients from East China. Antibiotics (Basel). 2023;12(9):1432.PubMedCrossRef Zhou S, Xiao S, Wang X, Wang X, Han L. Risk factors and pathogens of wound infection in burn inpatients from East China. Antibiotics (Basel). 2023;12(9):1432.PubMedCrossRef
14.
go back to reference Essayagh M, Essayagh T, Essayagh S, El Hamzaoui S. Epidemiology of burn wound infection in Rabat, Morocco: three-year review. Med Sante Trop. 2014;24(2):157–64.PubMed Essayagh M, Essayagh T, Essayagh S, El Hamzaoui S. Epidemiology of burn wound infection in Rabat, Morocco: three-year review. Med Sante Trop. 2014;24(2):157–64.PubMed
15.
go back to reference Organization WH. Antimicrobial resistance: global report on surveillance. World Health Organization; 2014. Organization WH. Antimicrobial resistance: global report on surveillance. World Health Organization; 2014.
16.
go back to reference Pulingam T, Parumasivam T, Gazzali AM, et al. Antimicrobial resistance: prevalence, economic burden, mechanisms of resistance and strategies to overcome. Eur J Pharm Sci. 2022;170: 106103.PubMedCrossRef Pulingam T, Parumasivam T, Gazzali AM, et al. Antimicrobial resistance: prevalence, economic burden, mechanisms of resistance and strategies to overcome. Eur J Pharm Sci. 2022;170: 106103.PubMedCrossRef
17.
go back to reference Gong Y, Peng Y, Luo X, et al. Different infection profiles and antimicrobial resistance patterns between burn ICU and common wards. Front Cell Infect Microbiol. 2021;11: 681731.PubMedPubMedCentralCrossRef Gong Y, Peng Y, Luo X, et al. Different infection profiles and antimicrobial resistance patterns between burn ICU and common wards. Front Cell Infect Microbiol. 2021;11: 681731.PubMedPubMedCentralCrossRef
18.
go back to reference Jin R, Yang M, Weng T, et al. Epidemiology and early bacteriology of extremely severe burns from an LPG tanker explosion in Eastern China. J Epidemiol Glob Health. 2022;12(4):478–85.PubMedPubMedCentralCrossRef Jin R, Yang M, Weng T, et al. Epidemiology and early bacteriology of extremely severe burns from an LPG tanker explosion in Eastern China. J Epidemiol Glob Health. 2022;12(4):478–85.PubMedPubMedCentralCrossRef
19.
20.
go back to reference Hoy D, Brooks P, Woolf A, et al. Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. J Clin Epidemiol. 2012;65(9):934–9.PubMedCrossRef Hoy D, Brooks P, Woolf A, et al. Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. J Clin Epidemiol. 2012;65(9):934–9.PubMedCrossRef
21.
go back to reference Yang Y, Zhang L, Wang J, et al. Proportions of Pseudomonas aeruginosa and antimicrobial-resistant P. aeruginosa among patients with surgical site infections in China: a systematic review and meta-analysis. Open Forum Infect Dis. 2024;11(2):ofad647.PubMedCrossRef Yang Y, Zhang L, Wang J, et al. Proportions of Pseudomonas aeruginosa and antimicrobial-resistant P. aeruginosa among patients with surgical site infections in China: a systematic review and meta-analysis. Open Forum Infect Dis. 2024;11(2):ofad647.PubMedCrossRef
22.
go back to reference Barendregt JJ, Doi SA, Lee YY, Norman RE, Vos T. Meta-analysis of prevalence. J Epidemiol Community Health. 2013;67(11):974–8.PubMedCrossRef Barendregt JJ, Doi SA, Lee YY, Norman RE, Vos T. Meta-analysis of prevalence. J Epidemiol Community Health. 2013;67(11):974–8.PubMedCrossRef
23.
26.
go back to reference Anderson-Sprecher R. Model comparisons and R2. Am Stat. 1994;48(2):113–7. Anderson-Sprecher R. Model comparisons and R2. Am Stat. 1994;48(2):113–7.
27.
go back to reference Zhang J, Zhang G, Zhu C, Yang K, Song M. Analysis of distribution of pathogens and change tendency of their antimicrobial resistances in burn patients in a hospital between the year 2016 and 2020. Chin J Burns Wounds Surf Ulcers. 2023;35(4):276–82 (85). Zhang J, Zhang G, Zhu C, Yang K, Song M. Analysis of distribution of pathogens and change tendency of their antimicrobial resistances in burn patients in a hospital between the year 2016 and 2020. Chin J Burns Wounds Surf Ulcers. 2023;35(4):276–82 (85).
28.
go back to reference Han C, Ji P, Shang Y, et al. Epidemiological characteristics of nosocomial infection in hospitalized children with burns and the establishment and verification of a risk prediction model. Chin J Burns Wounds. 2023;39(11):1006–13. Han C, Ji P, Shang Y, et al. Epidemiological characteristics of nosocomial infection in hospitalized children with burns and the establishment and verification of a risk prediction model. Chin J Burns Wounds. 2023;39(11):1006–13.
29.
go back to reference Hu J, Lu J. Analysis of distribution and drug resistance of pathogens in burn Intensive Care Unit. J Aerosp Med. 2023;34(10):1159–62. Hu J, Lu J. Analysis of distribution and drug resistance of pathogens in burn Intensive Care Unit. J Aerosp Med. 2023;34(10):1159–62.
30.
go back to reference Han F, Zhang S. Changes of distribution and drug resistance of pathogenic bacteria in burn inpatients in a general hospital. Int J Lab Med. 2022;43(2):183–7 (93). Han F, Zhang S. Changes of distribution and drug resistance of pathogenic bacteria in burn inpatients in a general hospital. Int J Lab Med. 2022;43(2):183–7 (93).
31.
go back to reference Li J, Fu X, Shen K, et al. Analysis of distribution and drug resistance of pathogens in wound infection of 249 burn patients. Chin J Nosocomiol. 2022;32(24):3742–6. Li J, Fu X, Shen K, et al. Analysis of distribution and drug resistance of pathogens in wound infection of 249 burn patients. Chin J Nosocomiol. 2022;32(24):3742–6.
32.
go back to reference Liu W, Cheng X, Liang Y, Guo Y. Distribution and antimicrobial resistance of pathogens of wound infection in patients with different burn areas. Chin J Infect Control. 2022;21(1):30–6. Liu W, Cheng X, Liang Y, Guo Y. Distribution and antimicrobial resistance of pathogens of wound infection in patients with different burn areas. Chin J Infect Control. 2022;21(1):30–6.
33.
go back to reference Wang H, Zhao P, Sun D, Wu X, Yuan Q, Wang K. Epidemiological characteristics and the establishment and evaluation of a risk prediction model for nosocomial infection in burn patients. Chin J Burns Wounds. 2022;38(12):1170–8. Wang H, Zhao P, Sun D, Wu X, Yuan Q, Wang K. Epidemiological characteristics and the establishment and evaluation of a risk prediction model for nosocomial infection in burn patients. Chin J Burns Wounds. 2022;38(12):1170–8.
34.
go back to reference Xu Y, Zhang G, Liu Y. Analysis of distribution and drug resistance of pathogenic bacteria in hospitalized patients with burn injuries. Chin Med J Metall Ind. 2022;39(2):217–8. Xu Y, Zhang G, Liu Y. Analysis of distribution and drug resistance of pathogenic bacteria in hospitalized patients with burn injuries. Chin Med J Metall Ind. 2022;39(2):217–8.
35.
go back to reference Yang J, Liu M, Pan W, Liang K, Zhao Y, Yao Z. Analysis of pathogens distribution and risk factors of burn infections in burn patients. Chin J Lab Med. 2022;45(9):950–6. Yang J, Liu M, Pan W, Liang K, Zhao Y, Yao Z. Analysis of pathogens distribution and risk factors of burn infections in burn patients. Chin J Lab Med. 2022;45(9):950–6.
36.
go back to reference Yu M, Zhou X, Chen Z, et al. Distribution and drug resistance analysis of pathogenic bacteria in burned patients. Hainan Med J. 2022;33(15):1962–6. Yu M, Zhou X, Chen Z, et al. Distribution and drug resistance analysis of pathogenic bacteria in burned patients. Hainan Med J. 2022;33(15):1962–6.
37.
go back to reference Zhu H, Qian H, Jiang J. Distribution and drug resistance of pathogenic bacteria on the wounds of burn patients in one hospital of Shaoxing. Int J Epidemiol Infect Dis. 2022;49(5):335–9. Zhu H, Qian H, Jiang J. Distribution and drug resistance of pathogenic bacteria on the wounds of burn patients in one hospital of Shaoxing. Int J Epidemiol Infect Dis. 2022;49(5):335–9.
38.
go back to reference Liao W. Retrospective investigation and analysis of pathogen distribution and drug resistance in severe burn patient. Nanchang: Nanchang University; 2021. Liao W. Retrospective investigation and analysis of pathogen distribution and drug resistance in severe burn patient. Nanchang: Nanchang University; 2021.
39.
go back to reference Zheng Y, Hu Q, Chi Y, et al. Analysis of wounds microbial culture in severe burn patients from 2015 to 2019. Chin J Med. 2021;56(06):616–9. Zheng Y, Hu Q, Chi Y, et al. Analysis of wounds microbial culture in severe burn patients from 2015 to 2019. Chin J Med. 2021;56(06):616–9.
40.
go back to reference Hu Y, Li D, Xu L, et al. Epidemiology and outcomes of bloodstream infections in severe burn patients: a six-year retrospective study. Antimicrob Resist Infect Control. 2021;10(1):98.PubMedPubMedCentralCrossRef Hu Y, Li D, Xu L, et al. Epidemiology and outcomes of bloodstream infections in severe burn patients: a six-year retrospective study. Antimicrob Resist Infect Control. 2021;10(1):98.PubMedPubMedCentralCrossRef
41.
go back to reference Liu J, Gao W, Wang J, Han Z, Jia S, Song L. Drug resistance of pathogens of venous catheter infections in children with extensive burn. Med J Chin PAP. 2020;31(05):386–8+93. Liu J, Gao W, Wang J, Han Z, Jia S, Song L. Drug resistance of pathogens of venous catheter infections in children with extensive burn. Med J Chin PAP. 2020;31(05):386–8+93.
42.
go back to reference Wu P, Sun L, Zheng X. Investigation on pathogenic bacteria and drug sensitivity of burn wound infection in some hospitals in Hangzhou from 2015 to 2018. Chin J Health Lab Technol. 2020;30(24):3039–41. Wu P, Sun L, Zheng X. Investigation on pathogenic bacteria and drug sensitivity of burn wound infection in some hospitals in Hangzhou from 2015 to 2018. Chin J Health Lab Technol. 2020;30(24):3039–41.
43.
go back to reference Chen Y-Y, Wu P-F, Chen C-S, Chen I-H, Huang W-T, Wang F-D. Trends in microbial profile of burn patients following an event of dust explosion at a tertiary medical center. BMC Infect Dis. 2020;20(1):193.PubMedPubMedCentralCrossRef Chen Y-Y, Wu P-F, Chen C-S, Chen I-H, Huang W-T, Wang F-D. Trends in microbial profile of burn patients following an event of dust explosion at a tertiary medical center. BMC Infect Dis. 2020;20(1):193.PubMedPubMedCentralCrossRef
44.
go back to reference Chang P, Ji R, Zhu H, et al. Analysis of bacterial distribution and drug resistance of burn patients in a hospital from 2014 to 2018. Chin Foreign Med Res. 2019;17(29):69–72. Chang P, Ji R, Zhu H, et al. Analysis of bacterial distribution and drug resistance of burn patients in a hospital from 2014 to 2018. Chin Foreign Med Res. 2019;17(29):69–72.
45.
go back to reference Liu Y, Huang X, Ma W, et al. Distribution and drug resistance of pathogens causing nosocomial infection in burn patients. Acad J Second Mil Univ. 2019;40(07):710–5. Liu Y, Huang X, Ma W, et al. Distribution and drug resistance of pathogens causing nosocomial infection in burn patients. Acad J Second Mil Univ. 2019;40(07):710–5.
46.
go back to reference Ouyang A, Mao C, Che J, Xu Y, Deng F, Deng F. Analysis of the distribution and drug resistance of pathogenic bacteria that infected burn patients in 2018. Nanchang; 2019. Ouyang A, Mao C, Che J, Xu Y, Deng F, Deng F. Analysis of the distribution and drug resistance of pathogenic bacteria that infected burn patients in 2018. Nanchang; 2019.
47.
go back to reference Wu X, Liao L, Wang F, Yin J. Characteristics and drug resistance of bacterial infections in inpatients with burn surgery. Chin J Gerontol. 2019;39(7):1647–9. Wu X, Liao L, Wang F, Yin J. Characteristics and drug resistance of bacterial infections in inpatients with burn surgery. Chin J Gerontol. 2019;39(7):1647–9.
48.
go back to reference Xu Z, Wang S, Mi C, Han L, Wang W. Analysis of distribution and drug resistance of pathogens in burned patients. J Shanghai Jiaotong Univ. 2019;39(3):292–6. Xu Z, Wang S, Mi C, Han L, Wang W. Analysis of distribution and drug resistance of pathogens in burned patients. J Shanghai Jiaotong Univ. 2019;39(3):292–6.
49.
go back to reference Fu Y, Yu F, Liu R, et al. Pathogenic bacteria and antimicrobial susceptibility of infected burn patients in the burn department from 2015 to 2016. J Shandong Med Coll. 2018;40(1):5–9. Fu Y, Yu F, Liu R, et al. Pathogenic bacteria and antimicrobial susceptibility of infected burn patients in the burn department from 2015 to 2016. J Shandong Med Coll. 2018;40(1):5–9.
50.
go back to reference Yang L, Wu C, Li Q, Wang Y, Ji G, Shan B. Analysis of species distribution and drug resistance of 2073 strains of bacteria isolated from burn wounds. Chin J Antibiot. 2018;43(5):577–82. Yang L, Wu C, Li Q, Wang Y, Ji G, Shan B. Analysis of species distribution and drug resistance of 2073 strains of bacteria isolated from burn wounds. Chin J Antibiot. 2018;43(5):577–82.
51.
go back to reference Zhang C, Gong Y, Luo X, Liu M, Peng Y. Analysis of distribution and drug resistance of pathogens from the wounds of 1310 thermal burn patients. Chin J Burns. 2018;34(11):802–8. Zhang C, Gong Y, Luo X, Liu M, Peng Y. Analysis of distribution and drug resistance of pathogens from the wounds of 1310 thermal burn patients. Chin J Burns. 2018;34(11):802–8.
52.
go back to reference Li L, Dai JX, Xu L, et al. Antimicrobial resistance and pathogen distribution in hospitalized burn patients: a multicenter study in Southeast China. Medicine (Baltimore). 2018;97(34): e11977.PubMedCrossRef Li L, Dai JX, Xu L, et al. Antimicrobial resistance and pathogen distribution in hospitalized burn patients: a multicenter study in Southeast China. Medicine (Baltimore). 2018;97(34): e11977.PubMedCrossRef
53.
go back to reference Lin TC, Wu RX, Chiu CC, et al. The clinical and microbiological characteristics of infections in burn patients from the Formosa Fun Coast dust explosion. J Microbiol Immunol Infect. 2018;51(2):267–77.PubMedCrossRef Lin TC, Wu RX, Chiu CC, et al. The clinical and microbiological characteristics of infections in burn patients from the Formosa Fun Coast dust explosion. J Microbiol Immunol Infect. 2018;51(2):267–77.PubMedCrossRef
54.
go back to reference Tang CQ, Li JQ, Shou BM, et al. Epidemiology and outcomes of bloodstream infections in 177 severe burn patients from an industrial disaster: a multicentre retrospective study. Clin Microbiol Infect. 2018;24(2):199 e1-e7.PubMedCrossRef Tang CQ, Li JQ, Shou BM, et al. Epidemiology and outcomes of bloodstream infections in 177 severe burn patients from an industrial disaster: a multicentre retrospective study. Clin Microbiol Infect. 2018;24(2):199 e1-e7.PubMedCrossRef
55.
go back to reference Chen X. Analysis of the distribution trend and drug resistance of pathogens causing infections in burn patients in Shi Jiazhuang. Shijiazhuang: Hebei Medical University; 2017. Chen X. Analysis of the distribution trend and drug resistance of pathogens causing infections in burn patients in Shi Jiazhuang. Shijiazhuang: Hebei Medical University; 2017.
56.
go back to reference Fan C, Di H, Xiang J, Tang Y. Distribution of pathogenic bacteria and analysis of drug resistance in burn inpatients of some hospital. J Logist Univ PAP. 2017;26(2):159–61. Fan C, Di H, Xiang J, Tang Y. Distribution of pathogenic bacteria and analysis of drug resistance in burn inpatients of some hospital. J Logist Univ PAP. 2017;26(2):159–61.
57.
go back to reference Lu K. Analysis of detection status and drug resistance changes of pathogenic bacteria caused by nosocomial infections in burn patients. World Latest Med Inf. 2017;17(91):278–9. Lu K. Analysis of detection status and drug resistance changes of pathogenic bacteria caused by nosocomial infections in burn patients. World Latest Med Inf. 2017;17(91):278–9.
58.
go back to reference Sun T. Comparative study on the characteristics and drug resistance of bacterial infections in inpatients with burn surgery and non-burn surgery. Contemp Med. 2017;23(3):102–3. Sun T. Comparative study on the characteristics and drug resistance of bacterial infections in inpatients with burn surgery and non-burn surgery. Contemp Med. 2017;23(3):102–3.
59.
go back to reference Tan J, Hu C, Yuan L, Lei G. Study on the etiological characteristics and risk factors of nosocomial infection in burn patients. Chongqing Med. 2017;46(15):2106–8. Tan J, Hu C, Yuan L, Lei G. Study on the etiological characteristics and risk factors of nosocomial infection in burn patients. Chongqing Med. 2017;46(15):2106–8.
60.
go back to reference Wang Y. Analysis of the use of antibacterial drugs and the distribution of pathogenic bacteria in patients of burns Department of People’s Hospital of Jiyuan. Chin J Burns Wounds Surf Ulcers. 2017;29(5):305–10. Wang Y. Analysis of the use of antibacterial drugs and the distribution of pathogenic bacteria in patients of burns Department of People’s Hospital of Jiyuan. Chin J Burns Wounds Surf Ulcers. 2017;29(5):305–10.
61.
go back to reference Xu Z, Wang S, Han L, Wang W. Analysis of distribution and drug resistance of pathogenic bacteria in burn wards. J Shanghai Jiaotong Univ. 2017;37(4):527–31. Xu Z, Wang S, Han L, Wang W. Analysis of distribution and drug resistance of pathogenic bacteria in burn wards. J Shanghai Jiaotong Univ. 2017;37(4):527–31.
62.
go back to reference Zhang Y, Cai L, Yang Y, et al. Investigation and analysis of drug resistance of pathogens of wound infections in burned patients. Chin J Nosocomiol. 2017;27(18):4198–201. Zhang Y, Cai L, Yang Y, et al. Investigation and analysis of drug resistance of pathogens of wound infections in burned patients. Chin J Nosocomiol. 2017;27(18):4198–201.
63.
go back to reference Zhang Z, Zhang L, Li C, Qi X, Jin S, Yang T. Clinical study on the distribution characteristics and prevention and treatment strategies of pathogenic bacteria in 161 patients with acute and severe burn injuries. Ningxia Med J. 2017;39(12):1155–8. Zhang Z, Zhang L, Li C, Qi X, Jin S, Yang T. Clinical study on the distribution characteristics and prevention and treatment strategies of pathogenic bacteria in 161 patients with acute and severe burn injuries. Ningxia Med J. 2017;39(12):1155–8.
64.
go back to reference Dai J, Li L, Xu L, et al. Analysis of distribution and drug resistance of pathogens isolated from 541 hospitalized children with burn infection. Chin J Burns. 2016;32(11):670–5. Dai J, Li L, Xu L, et al. Analysis of distribution and drug resistance of pathogens isolated from 541 hospitalized children with burn infection. Chin J Burns. 2016;32(11):670–5.
65.
go back to reference Li A. Analysis of drug resistance and prevention and control strategy of common pathogenic bacteria in burn ward. Qingdao: Qingdao University; 2016. Li A. Analysis of drug resistance and prevention and control strategy of common pathogenic bacteria in burn ward. Qingdao: Qingdao University; 2016.
66.
go back to reference Wang X, Su J, Wang Z, Fei Q, Jin X. Pathogenic bacteria distribution and drug resistance analysis of patients with large area burn. Chin J Nosocomiol. 2016;26(20):4689–91. Wang X, Su J, Wang Z, Fei Q, Jin X. Pathogenic bacteria distribution and drug resistance analysis of patients with large area burn. Chin J Nosocomiol. 2016;26(20):4689–91.
67.
go back to reference Yan J. Analysis of pathogen distribution and drug resistance of burn patients in our hospital from 2013 to 2015. China Pharm. 2016;27(35):4930–3. Yan J. Analysis of pathogen distribution and drug resistance of burn patients in our hospital from 2013 to 2015. China Pharm. 2016;27(35):4930–3.
68.
go back to reference Yin X, Xu X, Huang H, Shen X, Fang H. Analysis on infection pathogen and drug resistance of burned patients in dust explosion. Chin J Disinfect. 2016;33(11):1075–8. Yin X, Xu X, Huang H, Shen X, Fang H. Analysis on infection pathogen and drug resistance of burned patients in dust explosion. Chin J Disinfect. 2016;33(11):1075–8.
69.
go back to reference Zhang R, He Y, Pan W, Liu M. Analysis of infection etiology and drug resistance in burn patients in southern Yunnan. Med J Natl Defend Forces Southwest China. 2016;26(12):1513–6. Zhang R, He Y, Pan W, Liu M. Analysis of infection etiology and drug resistance in burn patients in southern Yunnan. Med J Natl Defend Forces Southwest China. 2016;26(12):1513–6.
70.
go back to reference Zhu J. Main bacteria and their drug-resistant trend that caused infection of burn patients in Wuxi during 2012–2014 and bacterial homology analysis in burn-ward’s environment. Suzhou: Soochow University; 2016. Zhu J. Main bacteria and their drug-resistant trend that caused infection of burn patients in Wuxi during 2012–2014 and bacterial homology analysis in burn-ward’s environment. Suzhou: Soochow University; 2016.
71.
go back to reference Zha B, Xu Q, Tang Y, Zhang J. Analysis of predominant pathogens of distribution and drug resistance in burn wards. Anhui Med J. 2015;36(5):536–40. Zha B, Xu Q, Tang Y, Zhang J. Analysis of predominant pathogens of distribution and drug resistance in burn wards. Anhui Med J. 2015;36(5):536–40.
72.
go back to reference Sun A, Wang W. Study on the distribution and drug resistance of pathogens in the infectious burn wound. Chin J Disinfect. 2015;32(12):1180–2. Sun A, Wang W. Study on the distribution and drug resistance of pathogens in the infectious burn wound. Chin J Disinfect. 2015;32(12):1180–2.
73.
go back to reference Tang W, Duan L, Chen L. Investigation and drug resistance analysis of bacterial infections in burn patients in Jingzhou City. J Yangtze Univ. 2015;12(24):39–41. Tang W, Duan L, Chen L. Investigation and drug resistance analysis of bacterial infections in burn patients in Jingzhou City. J Yangtze Univ. 2015;12(24):39–41.
74.
go back to reference Wang Y, Zheng D, Cheng D, Yan X. Distribution and drug resistance of pathogens causing burn wound infections. Chin J Nosocomiol. 2015;25(24):5663–5. Wang Y, Zheng D, Cheng D, Yan X. Distribution and drug resistance of pathogens causing burn wound infections. Chin J Nosocomiol. 2015;25(24):5663–5.
75.
go back to reference Yin G, Liu Z, Dong H, Lin R, Wei J, Zhao Z. Distribution and drug resistance of pathogens in burn department of a hospital in Ningxia from 2011 to 2013. Lab Med Clin. 2015;12(04):460–2. Yin G, Liu Z, Dong H, Lin R, Wei J, Zhao Z. Distribution and drug resistance of pathogens in burn department of a hospital in Ningxia from 2011 to 2013. Lab Med Clin. 2015;12(04):460–2.
76.
go back to reference Cen H, Wu Z, Wang F, Han C. Pathogen distribution and drug resistance in a burn ward: a three-year retrospective analysis of a single center in China. Int J Clin Exp Med. 2015;8(10):19188–99.PubMedPubMedCentral Cen H, Wu Z, Wang F, Han C. Pathogen distribution and drug resistance in a burn ward: a three-year retrospective analysis of a single center in China. Int J Clin Exp Med. 2015;8(10):19188–99.PubMedPubMedCentral
77.
go back to reference Chen C, Fan Y, Wu W, Xu X, Yang D. Distribution and drug susceptibility of pathogens causing wound infections in burn patients. Chin J Nosocomiol. 2014;24(04):841–3. Chen C, Fan Y, Wu W, Xu X, Yang D. Distribution and drug susceptibility of pathogens causing wound infections in burn patients. Chin J Nosocomiol. 2014;24(04):841–3.
78.
go back to reference Chen J, Jiang J. Analysis of bacterial resistance surveillance of infected patients in the burn department from 2010 to 2012. Int J Lab Med. 2014;35(01):111–3. Chen J, Jiang J. Analysis of bacterial resistance surveillance of infected patients in the burn department from 2010 to 2012. Int J Lab Med. 2014;35(01):111–3.
79.
go back to reference Dong Y, Zhang J, Li H, Yu F. Risk factors for nosocomial infections in burn wound patients. Chin J Nosocomiol. 2014;24(09):2265–6+9. Dong Y, Zhang J, Li H, Yu F. Risk factors for nosocomial infections in burn wound patients. Chin J Nosocomiol. 2014;24(09):2265–6+9.
80.
go back to reference Liu H. Analyze resistant of bacteria and homology of Pseudomonas aeruginosa in Yunnan Burn Center. Kunming: Kunming Medical University; 2014. p. 35. Liu H. Analyze resistant of bacteria and homology of Pseudomonas aeruginosa in Yunnan Burn Center. Kunming: Kunming Medical University; 2014. p. 35.
81.
go back to reference Peng Y, He Z, Jin Q. Analysis of pathogenic bacteria and drug susceptibility results of nosocomial infections in burn patients. J Chin Med. 2014;B12:350. Peng Y, He Z, Jin Q. Analysis of pathogenic bacteria and drug susceptibility results of nosocomial infections in burn patients. J Chin Med. 2014;B12:350.
82.
go back to reference Wang Y, Du H, Zhou L, Yu W, Wang Y, Sui Y. Distribution and drug resistance of pathogens isolated from wound of burn patients. Chin J Nosocomiol. 2014;24(13):3185–7. Wang Y, Du H, Zhou L, Yu W, Wang Y, Sui Y. Distribution and drug resistance of pathogens isolated from wound of burn patients. Chin J Nosocomiol. 2014;24(13):3185–7.
83.
go back to reference Xu X, Shi C, Zhang B, Cheng S, Song J, Tang Y. Common routes of infection after burn and analysis of its pathogen distribution and drug-resistance. J Dalian Med Univ. 2014;36(5):452–5 (9). Xu X, Shi C, Zhang B, Cheng S, Song J, Tang Y. Common routes of infection after burn and analysis of its pathogen distribution and drug-resistance. J Dalian Med Univ. 2014;36(5):452–5 (9).
84.
go back to reference Yali G, Jing C, Chunjiang L, Cheng Z, Xiaoqiang L, Yizhi P. Comparison of pathogens and antibiotic resistance of burn patients in the burn ICU or in the common burn ward. Burns. 2014;40(3):402–7.PubMedCrossRef Yali G, Jing C, Chunjiang L, Cheng Z, Xiaoqiang L, Yizhi P. Comparison of pathogens and antibiotic resistance of burn patients in the burn ICU or in the common burn ward. Burns. 2014;40(3):402–7.PubMedCrossRef
85.
go back to reference Alp E, Coruh A, Gunay GK, Yontar Y, Doganay M. Risk factors for nosocomial infection and mortality in burn patients: 10 years of experience at a university hospital. J Burn Care Res. 2012;33(3):379–85.PubMedCrossRef Alp E, Coruh A, Gunay GK, Yontar Y, Doganay M. Risk factors for nosocomial infection and mortality in burn patients: 10 years of experience at a university hospital. J Burn Care Res. 2012;33(3):379–85.PubMedCrossRef
86.
go back to reference Keen EF 3rd, Robinson BJ, Hospenthal DR, et al. Incidence and bacteriology of burn infections at a military burn center. Burns. 2010;36(4):461–8.PubMedCrossRef Keen EF 3rd, Robinson BJ, Hospenthal DR, et al. Incidence and bacteriology of burn infections at a military burn center. Burns. 2010;36(4):461–8.PubMedCrossRef
87.
go back to reference Chaudhary NA, Munawar MD, Khan MT, et al. Epidemiology, bacteriological profile, and antibiotic sensitivity pattern of burn wounds in the burn unit of a tertiary care hospital. Cureus. 2019;11(6): e4794.PubMedPubMedCentral Chaudhary NA, Munawar MD, Khan MT, et al. Epidemiology, bacteriological profile, and antibiotic sensitivity pattern of burn wounds in the burn unit of a tertiary care hospital. Cureus. 2019;11(6): e4794.PubMedPubMedCentral
88.
go back to reference Ekrami A, Kalantar E. Bacterial infections in burn patients at a burn hospital in Iran. Indian J Med Res. 2007;126(6):541–4.PubMed Ekrami A, Kalantar E. Bacterial infections in burn patients at a burn hospital in Iran. Indian J Med Res. 2007;126(6):541–4.PubMed
89.
go back to reference Honnegowda TM, Kumar P, Udupa P, Rao P. Epidemiological study of burn patients hospitalised at a burns centre, Manipal. Int Wound J. 2019;16(1):79–83.PubMedCrossRef Honnegowda TM, Kumar P, Udupa P, Rao P. Epidemiological study of burn patients hospitalised at a burns centre, Manipal. Int Wound J. 2019;16(1):79–83.PubMedCrossRef
90.
go back to reference Ozkacmaz A, Dicle Y, Bayram Y, Parlak M, Akis F, Calli I. The distribution and the antimicrobial susceptibility features of microorganisms isolated from the burn wounds; a ten-year retrospective analysis. J Burn Care Res. 2024;45(2):384–97.PubMedCrossRef Ozkacmaz A, Dicle Y, Bayram Y, Parlak M, Akis F, Calli I. The distribution and the antimicrobial susceptibility features of microorganisms isolated from the burn wounds; a ten-year retrospective analysis. J Burn Care Res. 2024;45(2):384–97.PubMedCrossRef
91.
go back to reference Foster TJ. The remarkably multifunctional fibronectin binding proteins of Staphylococcus aureus. Eur J Clin Microbiol Infect Dis. 2016;35(12):1923–31.PubMedCrossRef Foster TJ. The remarkably multifunctional fibronectin binding proteins of Staphylococcus aureus. Eur J Clin Microbiol Infect Dis. 2016;35(12):1923–31.PubMedCrossRef
92.
go back to reference Foster TJ. Surface proteins of Staphylococcus aureus. Microbiol Spectr. 2019;7(4):10–1128.CrossRef Foster TJ. Surface proteins of Staphylococcus aureus. Microbiol Spectr. 2019;7(4):10–1128.CrossRef
93.
go back to reference Arciola CR, Campoccia D, Gamberini S, Baldassarri L, Montanaro L. Prevalence of cna, fnbA and fnbB adhesin genes among Staphylococcus aureus isolates from orthopedic infections associated to different types of implant. FEMS Microbiol Lett. 2005;246(1):81–6.PubMedCrossRef Arciola CR, Campoccia D, Gamberini S, Baldassarri L, Montanaro L. Prevalence of cna, fnbA and fnbB adhesin genes among Staphylococcus aureus isolates from orthopedic infections associated to different types of implant. FEMS Microbiol Lett. 2005;246(1):81–6.PubMedCrossRef
94.
go back to reference Sedaghat H, Narimani T, Nasr Esfahani B, Mobasherizadeh S, Havaei SA. Comparison of the prevalence of microbial surface components recognizing adhesive matrix molecules (MSCRAMMs) among Staphylococcus aureus isolates in a burn unit with non-burning units. Iran J Public Health. 2021;50(1):146–51.PubMedPubMedCentral Sedaghat H, Narimani T, Nasr Esfahani B, Mobasherizadeh S, Havaei SA. Comparison of the prevalence of microbial surface components recognizing adhesive matrix molecules (MSCRAMMs) among Staphylococcus aureus isolates in a burn unit with non-burning units. Iran J Public Health. 2021;50(1):146–51.PubMedPubMedCentral
95.
go back to reference Severn MM, Horswill AR. Staphylococcus epidermidis and its dual lifestyle in skin health and infection. Nat Rev Microbiol. 2023;21(2):97–111.PubMedCrossRef Severn MM, Horswill AR. Staphylococcus epidermidis and its dual lifestyle in skin health and infection. Nat Rev Microbiol. 2023;21(2):97–111.PubMedCrossRef
96.
go back to reference Yoon J, Kym D, Hur J, et al. The clinical differentiation of blood culture-positive and -negative sepsis in burn patients: a retrospective cohort study. Burns Trauma. 2023;11:tkad031.PubMedPubMedCentralCrossRef Yoon J, Kym D, Hur J, et al. The clinical differentiation of blood culture-positive and -negative sepsis in burn patients: a retrospective cohort study. Burns Trauma. 2023;11:tkad031.PubMedPubMedCentralCrossRef
97.
go back to reference Yang X, Liu Y, Wang L, et al. Clonal and drug resistance dynamics of methicillin-resistant Staphylococcus aureus in pediatric populations in China. Pediatr Investig. 2019;3(2):72–80.PubMedPubMedCentralCrossRef Yang X, Liu Y, Wang L, et al. Clonal and drug resistance dynamics of methicillin-resistant Staphylococcus aureus in pediatric populations in China. Pediatr Investig. 2019;3(2):72–80.PubMedPubMedCentralCrossRef
98.
go back to reference Olearo F, Albrich WC, Vernaz N, Harbarth S, Kronenberg A, Swiss Centre For Antibiotic Resistance A. Staphylococcus aureus and methicillin resistance in Switzerland: regional differences and trends from 2004 to 2014. Swiss Med Wkly. 2016;146:w14339.PubMed Olearo F, Albrich WC, Vernaz N, Harbarth S, Kronenberg A, Swiss Centre For Antibiotic Resistance A. Staphylococcus aureus and methicillin resistance in Switzerland: regional differences and trends from 2004 to 2014. Swiss Med Wkly. 2016;146:w14339.PubMed
99.
go back to reference Amorim ML, Faria NA, Oliveira DC, et al. Changes in the clonal nature and antibiotic resistance profiles of methicillin-resistant Staphylococcus aureus isolates associated with spread of the EMRSA-15 clone in a tertiary care Portuguese hospital. J Clin Microbiol. 2007;45(9):2881–8.PubMedPubMedCentralCrossRef Amorim ML, Faria NA, Oliveira DC, et al. Changes in the clonal nature and antibiotic resistance profiles of methicillin-resistant Staphylococcus aureus isolates associated with spread of the EMRSA-15 clone in a tertiary care Portuguese hospital. J Clin Microbiol. 2007;45(9):2881–8.PubMedPubMedCentralCrossRef
100.
go back to reference Otter JA, French GL. Community-associated meticillin-resistant Staphylococcus aureus strains as a cause of healthcare-associated infection. J Hosp Infect. 2011;79(3):189–93.PubMedCrossRef Otter JA, French GL. Community-associated meticillin-resistant Staphylococcus aureus strains as a cause of healthcare-associated infection. J Hosp Infect. 2011;79(3):189–93.PubMedCrossRef
101.
go back to reference Organization WH. Global action plan on antimicrobial resistance. 2015. Organization WH. Global action plan on antimicrobial resistance. 2015.
102.
go back to reference Tao Y, Wang Y, Zhang Y, et al. A qualitative study of the factors impacting implementation of the national action plan to contain antimicrobial resistance (2016–2020) in medical institutions. BMC Health Serv Res. 2024;24(1):120.PubMedPubMedCentralCrossRef Tao Y, Wang Y, Zhang Y, et al. A qualitative study of the factors impacting implementation of the national action plan to contain antimicrobial resistance (2016–2020) in medical institutions. BMC Health Serv Res. 2024;24(1):120.PubMedPubMedCentralCrossRef
104.
go back to reference Gupta M, Naik AK, Singh SK. Bacteriological profile and antimicrobial resistance patterns of burn wound infections in a tertiary care hospital. Heliyon. 2019;5(12): e02956.PubMedPubMedCentralCrossRef Gupta M, Naik AK, Singh SK. Bacteriological profile and antimicrobial resistance patterns of burn wound infections in a tertiary care hospital. Heliyon. 2019;5(12): e02956.PubMedPubMedCentralCrossRef
105.
go back to reference Bayram Y, Parlak M, Aypak C, Bayram I. Three-year review of bacteriological profile and antibiogram of burn wound isolates in Van, Turkey. Int J Med Sci. 2013;10(1):19–23.PubMedCrossRef Bayram Y, Parlak M, Aypak C, Bayram I. Three-year review of bacteriological profile and antibiogram of burn wound isolates in Van, Turkey. Int J Med Sci. 2013;10(1):19–23.PubMedCrossRef
106.
go back to reference Lin XC, Li CL, Zhang SY, Yang XF, Jiang M. The global and regional prevalence of hospital-acquired carbapenem-resistant Klebsiella pneumoniae infection: a systematic review and meta-analysis. Open Forum Infect Dis. 2024;11(2):ofad649.PubMedCrossRef Lin XC, Li CL, Zhang SY, Yang XF, Jiang M. The global and regional prevalence of hospital-acquired carbapenem-resistant Klebsiella pneumoniae infection: a systematic review and meta-analysis. Open Forum Infect Dis. 2024;11(2):ofad649.PubMedCrossRef
107.
go back to reference Darby EM, Trampari E, Siasat P, et al. Molecular mechanisms of antibiotic resistance revisited. Nat Rev Microbiol. 2023;21(5):280–95.PubMedCrossRef Darby EM, Trampari E, Siasat P, et al. Molecular mechanisms of antibiotic resistance revisited. Nat Rev Microbiol. 2023;21(5):280–95.PubMedCrossRef
108.
go back to reference Shao F, Ren WJ, Meng WZ, Wang GZ, Wang TY. Burn wound bacteriological profiles, patient outcomes, and tangential excision timing: a prospective, observational study. Ostomy Wound Manag. 2018;64(9):28–36.CrossRef Shao F, Ren WJ, Meng WZ, Wang GZ, Wang TY. Burn wound bacteriological profiles, patient outcomes, and tangential excision timing: a prospective, observational study. Ostomy Wound Manag. 2018;64(9):28–36.CrossRef
109.
go back to reference Luo G, Tan J, Peng Y, et al. Guideline for diagnosis, prophylaxis and treatment of invasive fungal infection post burn injury in China 2013. Burns Trauma. 2014;2(2):45–52.PubMedPubMedCentralCrossRef Luo G, Tan J, Peng Y, et al. Guideline for diagnosis, prophylaxis and treatment of invasive fungal infection post burn injury in China 2013. Burns Trauma. 2014;2(2):45–52.PubMedPubMedCentralCrossRef
110.
go back to reference Babb J, Clark A, Gaffney D, Abdelfattah K, Prokesch BC. Little utility of fungal blood cultures in surgical and burn intensive care units. Microbiol Spectr. 2022;10(4): e0022822.PubMedCrossRef Babb J, Clark A, Gaffney D, Abdelfattah K, Prokesch BC. Little utility of fungal blood cultures in surgical and burn intensive care units. Microbiol Spectr. 2022;10(4): e0022822.PubMedCrossRef
111.
go back to reference Köhler JR, Hube B, Puccia R, Casadevall A, Perfect JR. Fungi that infect humans. Microbiol Spectr. 2017;5(3):5.3.08.CrossRef Köhler JR, Hube B, Puccia R, Casadevall A, Perfect JR. Fungi that infect humans. Microbiol Spectr. 2017;5(3):5.3.08.CrossRef
112.
go back to reference Chayakulkeeree M, Ghannoum M, Perfect J. Zygomycosis: the re-emerging fungal infection. Eur J Clin Microbiol Infect Dis. 2006;25:215–29.PubMedCrossRef Chayakulkeeree M, Ghannoum M, Perfect J. Zygomycosis: the re-emerging fungal infection. Eur J Clin Microbiol Infect Dis. 2006;25:215–29.PubMedCrossRef
113.
go back to reference Zhou J, Tan J, Gong Y, Li N, Luo G. Candidemia in major burn patients and its possible risk factors: a 6-year period retrospective study at a burn ICU. Burns. 2019;45(5):1164–71.PubMedCrossRef Zhou J, Tan J, Gong Y, Li N, Luo G. Candidemia in major burn patients and its possible risk factors: a 6-year period retrospective study at a burn ICU. Burns. 2019;45(5):1164–71.PubMedCrossRef
114.
go back to reference Vaezi A, Fakhim H, Khodavaisy S, et al. Epidemiological and mycological characteristics of candidemia in Iran: a systematic review and meta-analysis. J Mycol Med. 2017;27(2):146–52.PubMedCrossRef Vaezi A, Fakhim H, Khodavaisy S, et al. Epidemiological and mycological characteristics of candidemia in Iran: a systematic review and meta-analysis. J Mycol Med. 2017;27(2):146–52.PubMedCrossRef
115.
go back to reference Rodriguez L, Bustamante B, Huaroto L, et al. A multi-centric study of Candida bloodstream infection in Lima-Callao, Peru: species distribution, antifungal resistance and clinical outcomes. PLoS ONE. 2017;12(4): e0175172.PubMedPubMedCentralCrossRef Rodriguez L, Bustamante B, Huaroto L, et al. A multi-centric study of Candida bloodstream infection in Lima-Callao, Peru: species distribution, antifungal resistance and clinical outcomes. PLoS ONE. 2017;12(4): e0175172.PubMedPubMedCentralCrossRef
116.
go back to reference Ronat JB, Kakol J, Khoury MN, et al. Highly drug-resistant pathogens implicated in burn-associated bacteremia in an Iraqi burn care unit. PLoS ONE. 2014;9(8): e101017.PubMedPubMedCentralCrossRef Ronat JB, Kakol J, Khoury MN, et al. Highly drug-resistant pathogens implicated in burn-associated bacteremia in an Iraqi burn care unit. PLoS ONE. 2014;9(8): e101017.PubMedPubMedCentralCrossRef
117.
go back to reference Dighriri IM, Alnomci BA, Aljahdali MM, et al. The role of clinical pharmacists in Antimicrobial Stewardship Programs (ASPs): a systematic review. Cureus. 2023;15(12): e50151.PubMedPubMedCentral Dighriri IM, Alnomci BA, Aljahdali MM, et al. The role of clinical pharmacists in Antimicrobial Stewardship Programs (ASPs): a systematic review. Cureus. 2023;15(12): e50151.PubMedPubMedCentral
118.
go back to reference Wang Y, Zhang X, Zhou Q, Xu X. Impact of selective reporting of antimicrobial susceptibility testing report on clinicians’ prescribing behavior of antibiotics. Front Pharmacol. 2023;14:1225531.PubMedPubMedCentralCrossRef Wang Y, Zhang X, Zhou Q, Xu X. Impact of selective reporting of antimicrobial susceptibility testing report on clinicians’ prescribing behavior of antibiotics. Front Pharmacol. 2023;14:1225531.PubMedPubMedCentralCrossRef
Metadata
Title
Distribution of Nosocomial Pathogens and Antimicrobial Resistance among Patients with Burn Injuries in China: A Comprehensive Research Synopsis and Meta-Analysis
Authors
Yuhui Yang
Qingling Zeng
Guangyun Hu
Zhenkun Wang
Zongyue Chen
Lang Zhou
Aibo He
Wei Qian
Yu Luo
Gaoming Li
Publication date
09-05-2024
Publisher
Springer Healthcare
Published in
Infectious Diseases and Therapy / Issue 6/2024
Print ISSN: 2193-8229
Electronic ISSN: 2193-6382
DOI
https://doi.org/10.1007/s40121-024-00983-6

Other articles of this Issue 6/2024

Infectious Diseases and Therapy 6/2024 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Webinar | 06-02-2024 | 20:00 (CET)

Mastering chronic pancreatitis pain: A multidisciplinary approach and practical solutions

Severe pain is the most common symptom of chronic pancreatitis. In this webinar, experts share the latest insights in pain management for chronic pancreatitis patients. Experts from a range of disciplines discuss pertinent cases and provide practical suggestions for use within clinical practice.

Sponsored by: Viatris

Developed by: Springer Healthcare
Live Webinar | 01-10-2024 | 12:30 (CEST)

Recent advances in the use of CAR T-cell therapies in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma

Live: Tuesday 1st October 2024, 12:30-14:00 (CEST)

In this live webinar, Professor Martin Dreyling and an esteemed, international panel of CAR-T experts will discuss the very latest data on the safety, efficacy and clinical impact of CAR T-cell therapies in the treatment of r/r DLBCL and r/r FL, as presented at ASH 2023, EU CAR-T 2024, and EHA 2024. 

Please note, this webinar is not intended for healthcare professionals based in the US and UK.

Sponsored by: Novartis Pharma AG

Chaired by: Prof. Martin Dreyling
Developed by: Springer Healthcare